QRG Capital Management Inc. Cuts Holdings in Humana Inc. $HUM

QRG Capital Management Inc. reduced its position in Humana Inc. (NYSE:HUM) by 10.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,479 shares of the insurance provider’s stock after selling 286 shares during the quarter. QRG Capital Management Inc.’s holdings in Humana were worth $606,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. Cary Street Partners Investment Advisory LLC lifted its stake in shares of Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 46 shares during the last quarter. Applied Finance Capital Management LLC lifted its stake in shares of Humana by 1.7% in the 1st quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider’s stock valued at $779,000 after purchasing an additional 48 shares during the last quarter. Achmea Investment Management B.V. lifted its stake in shares of Humana by 0.5% in the 1st quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider’s stock valued at $2,746,000 after purchasing an additional 49 shares during the last quarter. Beech Hill Advisors Inc. lifted its stake in shares of Humana by 6.1% in the 1st quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider’s stock valued at $229,000 after purchasing an additional 50 shares during the last quarter. Finally, Atlas Brown Inc. lifted its stake in shares of Humana by 0.9% in the 2nd quarter. Atlas Brown Inc. now owns 6,369 shares of the insurance provider’s stock valued at $1,557,000 after purchasing an additional 54 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

HUM has been the subject of several analyst reports. Guggenheim reaffirmed a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Wells Fargo & Company lifted their target price on shares of Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a report on Tuesday. Truist Financial dropped their target price on shares of Humana from $280.00 to $260.00 and set a “hold” rating on the stock in a report on Wednesday, July 16th. Piper Sandler dropped their target price on shares of Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a report on Thursday, July 31st. Finally, Mizuho lifted their target price on shares of Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a report on Thursday. Seven equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $298.71.

Humana Stock Performance

NYSE:HUM opened at $290.11 on Friday. The firm’s 50-day moving average is $278.79 and its 200-day moving average is $258.16. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $315.35. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The company has a market cap of $34.89 billion, a price-to-earnings ratio of 22.27, a PEG ratio of 1.75 and a beta of 0.42.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. Equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. Humana’s payout ratio is presently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.